the (almost) radical rebirth of King’s Cross

The almost quarter-century-long, kilometer-long, 67-hectare project to redevelop King’s Cross in London is a monument of its time. It is the urban embodiment of the Blair era in which it was conceived, of the Third Way, of the idea that market forces, wisely guided by light-hearted government, can be a force for good. It will … Read more

Synthetic human embryos allow researchers to study early development while bypassing ethical and logistical hurdles

Embryonic development, also called embryogenesis, is a cornerstone in understanding the origins of life. But studying this marvel of complex and layered biological processes in humans faces significant challenges. Early stage human embryos are difficult to obtain. Then there are ethical issues surrounding its use. This has made it difficult for scientists to understand early … Read more

CRISPR and other new technologies open doors for drug development, but which diseases get priority? It comes down to money and science

Prescription drugs and vaccines revolutionized healthcare, dramatically reducing deaths from diseases and improving the quality of life around the world. But how do researchers, universities, hospitals and the pharmaceutical industry decide which diseases to develop drugs for? In my work as director of the Health Outcomes, Policy, and Evidence Synthesis group at the University of … Read more